ArticleFrontiers in immunology2026
Identification of CCND1 and IL7R as core JAK-STAT pathway genes promoting hepatitis B-related liver fibrosis.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Macrophages in oncoviral infections: from immune regulators to therapeutic targets.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Liver fibrosis is one of the most common complications in patients with HBV infection. Characterized by excessive extracellular matrix deposition and hepatic stellate cell activation, it is tightly linked to the JAK-STAT pathway that regulates inflammatory and fibrogenic processes. Methods: The GSE84044 dataset was retrieved from the GEO database. After grouping and preprocessing, DEGs were screened with the limma package and then subjected to functional enrichment analysis. WGCNA was performed to identify fibrosis-related module genes. Candidate key genes were obtained by intersecting these WGCNA module genes with the DEGs and JAK-STAT genes. A diagnostic model was constructed via machine learning algorithms to further filter core genes. Subsequently, GSEA, GSVA and immune infiltration analysis were conducted to explore the biological functions of these core genes. Mendelian randomization (MR) was employed to verify the causal relationships among the target genes. Furthermore, the miRNA-mRNA-TF network of the core genes were constructed. ScRNA analysis was performed to validated our finding. Finally, the expression levels of core genes were experimentally validated by Western blot and qPCR. Results: CCND1 and IL7R were identified as hub genes of the JAK-STAT pathway through integrated analyses. Both genes are significantly upregulated and exert synergistic effects in HBV-related liver fibrosis, with the constructed diagnostic model achieving an AUC of 0.890. Functional enrichment indicated their involvement in immune regulatory and fibrotic pathways, while immune infiltration analysis revealed a close association with M1 macrophages and other immune cell subsets. MR analysis confirmed a significant positive causal effect of IL7R on liver fibrosis. The miRNA-mRNA-TF regulatory network highlighted their post-transcriptional and transcriptional regulatory mechanisms. scRNA-seq validated cell-type-specific expression patterns of CCND1 (epithelial cells, endothelial cells, hepatocytes, macrophages) and IL7R (T/NK cells). Western blot and qPCR further confirmed the upregulation of these genes in HBV-related fibrotic liver tissues at both protein and mRNA levels. Conclusions: In summary, CCND1 and IL7R are core JAK-STAT pathway genes associated with HBV-related liver fibrosis, with IL7R showing a significant causal role. They regulate immune microenvironment and may serve as diagnostic biomarkers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.